ABL1 and acute lymphoblastic leukemia: From these, BCL2 was validated as a direct target of the miR-17 and miR-18a, and BCL2 knockdown resulted in strong induction of apoptosis in BCR-ABL-positive, but not BCR-ABL-negative ALL cells.